A Aforeworn
Forewarned is forearmed.
Home › Niches › Pharmacy & Controlled Substances › Change
Medium urgency

GLP-1 Drugs: Ohio Board of Pharmacy Issues FAQs for Compounders - The National Law Review

Detected July 24, 2026 · in Pharmacy & Controlled Substances

Ohio Board of Pharmacy issued FAQs clarifying compounding rules for GLP-1 drugs, impacting compounding pharmacies and independent pharmacies that compound these medications.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 24, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Compounding pharmacies and independent pharmacies in Ohio that compound GLP-1 drugs should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; no specific deadline given, but compliance should be ensured before next inspection or audit.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

Ohio Board of Pharmacy released FAQs providing guidance on compounding GLP-1 drugs, likely addressing USP <795> and <797> standards, and clarifying when compounding is allowed (e.g., due to drug shortages).

Who it affects

Compounding pharmacies and independent pharmacies in Ohio that compound GLP-1 drugs

What you must do

Review the FAQs and ensure compounding practices for GLP-1 drugs comply with Ohio Board of Pharmacy requirements, including proper documentation and adherence to USP standards.

Deadline

Immediately; no specific deadline given, but compliance should be ensured before next inspection or audit.

Source: https://news.google.com/rss/articles/CBMikgFBVV95cUxNTXFOQ1VfSk5WWXhiVGtsTlppZFppMG9GUkZQR29TSHBoM2lQa3IxVGx3UHdocndjS1FKbUxjUDdka29PZ0lWbDR0RVRaNm5yQVdUMF9xQ0pCMXJuVGtOV05aTzdCWTF4YjZJQlBCVXdzQjNEamVRVlZ6SjRoWHBfaUNGX3FFX0ZheWFuUWZ0NXotQdIBlwFBVV95cUxNNmNnbElybnByTE9kNkJkWmE5ZGVJeTAzaXBWdFd6U0xCSlN2MTQ1WnBJRWVnUWFIUl84ZEYzQzc3cHdqTGxLMXdzY3FkSnQ1U2NQcWFJS3Z0YllCOUJuZXBtYUU4ZDROVkQteWNNZ3BsaE1vVWNLajNXQ1k4T3E5SmlQckNtRVBTTmw3Y3FsQVZ3bkpsWldz?oc=5

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances